B. Zhang

发表

Detection of insulin receptor tyrosine kinase activity using time-resolved fluorescence energy transfer technology.

D. Moller, D. E. Biazzo-Ashnault, Y. W. Park, 2001, Analytical biochemistry.

Insulin- and Mitogen-activated Protein Kinase-mediated Phosphorylation and Activation of Peroxisome Proliferator-activated Receptor γ*

G. Zhou, J. Berger, D. Moller, 1996, The Journal of Biological Chemistry.

Potentiation of insulin stimulation of phosphatidylinositol 3-kinase by thiazolidinedione-derived antidiabetic agents in Chinese hamster ovary cells expressing human insulin receptors and L6 myotubes.

J. Berger, B. Zhang, D. Szalkowski, 1994, The Journal of biological chemistry.

Substrates and signalling complexes: The tortured path to insulin action

R. Roth, K. Kovacina, B. Zhang, 1992, Journal of cellular biochemistry.

Insulin action in cultured human skeletal muscle cells during differentiation: assessment of cell surface GLUT4 and GLUT1 content

J. Zierath, A. Krook, A. Chibalin, 2003, Cellular and Molecular Life Sciences CMLS.

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.

B. Spiegelman, J. Berger, D. Moller, 1996, Molecular endocrinology.

Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.

J. Berger, B. Zhang, S. White-Carrington, 1995, Endocrinology.

A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies.

R. Roth, B. Zhang, B. Zhang, 1991, Proceedings of the National Academy of Sciences of the United States of America.

New approaches in the treatment of type 2 diabetes.

D. Moller, B. Zhang, David E. Moller, 2000, Current opinion in chemical biology.

Small molecule insulin receptor activators potentiate insulin action in insulin-resistant cells.

B. Zhang, J. Youngren, I. Goldfine, 2001, Diabetes.

RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice

T. Vogt, J. Berger, B. Zhang, 2010, International Journal of Obesity.

A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.

A. Ullrich, K. Siddle, R. Roth, 1992, The Journal of biological chemistry.

The insulin receptor-related receptor. Tissue expression, ligand binding specificity, and signaling capabilities.

R. Roth, B. Zhang, B. Zhang, 1992, The Journal of biological chemistry.

PI 3-kinase activation is required for insulin stimulation of glucose transport into L6 myotubes.

J. Berger, B. Zhang, D. Szalkowski, 1994, Biochemical and biophysical research communications.

Insulin receptor-related receptor messenger ribonucleic acid is focally expressed in sympathetic and sensory neurons and renal distal tubule cells.

R. Roth, B. Zhang, R. Reinhardt, 1993, Endocrinology.

Insulin-stimulated serine and threonine phosphorylation of the human insulin receptor. An assessment of the role of serines 1305/1306 and threonine 1348 by their replacement with neutral or negatively charged amino acids.

J. Tavaré, R. Roth, B. Zhang, 1991, The Journal of biological chemistry.

The basal SAR of a novel insulin receptor activator.

D. Moller, B. Zhang, D. Szalkowski, 2000, Bioorganic & medicinal chemistry letters.

A novel insulin mimetic without a proliferative effect on vascular smooth muscle cells.

A. Sidawy, B. Zhang, M. Weber, 2000, Journal of vascular surgery.

Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptor.

D. Moller, V. Ding, B. Zhang, 2000, Journal of medicinal chemistry.

Discovery of a small molecule insulin mimetic with antidiabetic activity in mice.

R G Smith, D. Moller, J. Zierath, 1999, Science.

AMPK activators – potential therapeutics for metabolic and other diseases

G. Zhou, B. Zhang, I. Sebhat, 2009, Acta physiologica.

Inhibition of adipocyte differentiation by HIV protease inhibitors.

J. Berger, D. Moller, B. Zhang, 1999, The Journal of clinical endocrinology and metabolism.

Discovery of a small molecule insulin receptor activator.

B. Zhang, G. Salituro, F. Peláez, 2001, Recent progress in hormone research.

Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.

J. Berger, D. Moller, J. Zierath, 1998, Endocrinology.

The Response of Glucose‐Excited Neurones in the Ventromedial Hypothalamus to Decreased Glucose is Enhanced in a Murine Model of Type 2 Diabetes Mellitus

V. Routh, B. Zhang, V. Cotero, 2010, Journal of neuroendocrinology.